Archive for November, 2009

Novavax Acts as Leaderboard Stock (NVAX)

Novavax, Inc. (NASDAQ: NVAX) may show how little key impact news there is, but it is the top mover today in percentage terms seen.  At 8:28 AM EST we have seen 75,000 shares trade (versus 6 million average) and the stock is up 6.6% at $3.20.  This is on news that it has completed enrollment [...]

Baidu Cut Close to 52-week Highs (BIDU)

Baidu, Inc. (NASDAQ: BIDU) is under pressure this morning on an analyst downgrade to Market Perform from Outperform at Bernstein.  At 8:25 AM EST we have seen only about 24,000 shares traded and the stock is down less than 1% at $436.00 on the last print.  The 52-week trading range is $100.50 to $443.25.  A [...]

Sinovac Gets a Small Boost (SVA)

Sinovac Biotech Ltd. (NASDAQ: SVA) is indicated higher this morning after the Chinese drug and biotech player was Reiterated as Overweight with an $11 target at Piper Jaffray.  At 8:17 AM EST we have only seen 8,000 shares trade and the gain is only 1.9% ahead of conference data,  Last week the company announced a [...]

US Steel Loves Goldman Conviction Buy (X, FCX)

US Steel Corp. (NYSE: X) is trading up this morning after it was added to Goldman Sachs’ coveted Conviction Buy List to replace Freeport McMoran (NYSE: FCX).  At 8:10 AM EST this has shares up almost 4% at $44.72 in the very early indications this morning on almost 75,000 shares.  The volume will increase as [...]

Sequenom Plays Give-Back (SQNM)

Sequenom, Inc. (NASDAQ: SQNM) is getting clipped this morning before the open.  At 9:25 AM EST we have shares down 7.9% from the $4.42 close down at $4.07 this morning. All we have seen is a call on the wires from a Skymark Research and that is just an advertisement of a call that is [...]

Incyte Passes 52-Week Highs (INCY, NVS)

Incyte Corp (NASDAQ:INCY) announced that it has signed a collaboration and license agreement with Novartis (NYSE: NVS) for two of its investigational haematology and oncology therapies. Novartis could end up paying $1.1 billion in total under the pact if milestones are reached.  Novartis will pay $150 million to Incyte up front, with an immediate $60 [...]

Origin Agritech Day Two (SEED)

Origin Agritech Limited (NASDAQ: SEED) is continuing yesterday’s surge on a genetic corn approval.  At 8:43 AM EST we have already seen 1.45 million shares trade hands and the stock is up 7% at $11.19.  Shares had been up as high as $11.40 in earlier indications but that is pre-market and won’t count unless the [...]

TiVo Scores Google (TIVO)

TiVo Inc. (NASDAQ: TIVO) is trading higher this morning, although on thinner volume than we’d like to see.  The company signed an advertising data pact where Google will use its data in analysis of video advertising for which ads get skipped in recordings.  Shares are up 3.9% at $11.15 at 8:39 AM EST and we [...]

Brocade Softens

Brocade Communications Systems, Inc. (NASDAQ: BRCD) is down slightly after beating expectations as the company reported Q4 results $0.15 EPS and $521.8 million in revenues vs. consensus of $0.13 EPS and $521.09 revenues.  At 8:24 we have shares down only about 2% at $7.63.  But we also have seen over 1.1 million shares trade hands. [...]

Amylin Upgrade Soar (AMLN)

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) was raised to overweight this morning by BGarclays as seen in our top ten analyst calls.  Apparently, shares are taking it to heart immediately.  At 8:18 AM EST we have seen 50,000 shares trade hands, yet shares are up over 10% at $13.80 after a $12.47 close.  The average volume [...]